APA (7th ed.) Citation

MK, R., D, H., SK, D. M., DK, P., P, M., & A, S. (2025). A group sequential response-adaptive randomized double-blinded clinical trial to evaluate the safety and efficacy of add-on olanzapine plus pregabalin for the prevention of chemotherapy-induced nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(3), 203. https://doi.org/10.1007/s00520-025-09275-2

Chicago Style (17th ed.) Citation

MK, Ramasubbu, Hota D, Das Majumdar SK, Parida DK, Mukherjee P, and Srinivasan A. "A Group Sequential Response-adaptive Randomized Double-blinded Clinical Trial to Evaluate the Safety and Efficacy of Add-on Olanzapine Plus Pregabalin for the Prevention of Chemotherapy-induced Nausea and Vomiting." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 33, no. 3 (2025): 203. https://doi.org/10.1007/s00520-025-09275-2.

MLA (9th ed.) Citation

MK, Ramasubbu, et al. "A Group Sequential Response-adaptive Randomized Double-blinded Clinical Trial to Evaluate the Safety and Efficacy of Add-on Olanzapine Plus Pregabalin for the Prevention of Chemotherapy-induced Nausea and Vomiting." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 33, no. 3, 2025, p. 203, https://doi.org/10.1007/s00520-025-09275-2.